Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;134(2):139-55.
doi: 10.1016/j.pharmthera.2012.01.004. Epub 2012 Jan 16.

Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury

Affiliations
Review

Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury

Philip R Mayeux et al. Pharmacol Ther. 2012 May.

Abstract

One of the most frequent and serious complications to develop in septic patients is acute kidney injury (AKI), a disorder characterized by a rapid failure of the kidneys to adequately filter the blood, regulate ion and water balance, and generate urine. AKI greatly worsens the already poor prognosis of sepsis and increases cost of care. To date, therapies have been mostly supportive; consequently there has been little change in the mortality rates over the last decade. This is due, at least in part, to the delay in establishing clinical evidence of an infection and the associated presence of the systemic inflammatory response syndrome and thus, a delay in initiating therapy. A second reason is a lack of understanding regarding the mechanisms leading to renal injury, which has hindered the development of more targeted therapies. In this review, we summarize recent studies, which have examined the development of renal injury during sepsis and propose how changes in the peritubular capillary microenvironment lead to and then perpetuate microcirculatory failure and tubular epithelial cell injury. We also discuss a number of potential therapeutic targets in the renal peritubular microenvironment, which may prevent or lessen injury and/or promote recovery.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Anatomy of the renal circulation
The renal microcirculation is depicted illustrating the anatomical relationship between the renal tubules and the peritubular capillaries.
Figure 2
Figure 2
Schematic showing the synthesis of oxidant derived from NO and superoxide.
Figure 3
Figure 3. Imaging of RNS generation in renal tubules with intravital microscopy
Shown are representative images of perfusion (A) and rhodamine fluorescence (B) captured from videos of the same field of view from the kidney of a live 40-week-old mouse 16 hours after CLP. Arrows indicate capillaries with no perfusion. A pseudocolored image of B is shown in C to highlight changes in pixel intensity. Intense regions of rhodamine fluorescence are localized to discrete regions of the tubular epithelium bordered by capillaries with reduced perfusion (from (L. Wu, Gokden, et al., 2007) used with permission).
Figure 4
Figure 4
Depiction of the mitochondrial electron transport chain.
Figure 5
Figure 5. Changes in the peritubular capillary microenvironment during sepsis
Depicted in A is the normal peritubular capillary microenvironment. The early impaired microcirculation with increased capillary permeability and decrease capillary perfusion are depicted in B. Subsequent tubular epithelial damage is depicted in C.
Figure 6
Figure 6. Sepsis-induced cycle of injury in the peritubular microenvironment
Green arrows indicate events, which may occur too rapidly to be clinically relevant therapeutic targets. Red arrows indicate possible targets in the peritubular microenvironment, which could break the cycle of injury and allow recovery of the renal microcirculation and tubular function.

Similar articles

Cited by

References

    1. Abrahamson DR, Leardkamolkarn V. Development of kidney tubular basement membranes. Kidney International. 1991;39:382–393. - PubMed
    1. Ader I, Malavaud B, Cuvillier O. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. Cancer Research. 2009;69:3723–3726. - PubMed
    1. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB Journal. 2005;19:1088–1095. - PubMed
    1. Al-Mashhadi RH, Skott O, Vanhoutte PM, Hansen PB. Activation of A(2) adenosine receptors dilates cortical efferent arterioles in mouse. Kidney International. 2009;75:793–799. - PubMed
    1. Allende ML, Yamashita T, Proia RL. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood. 2003;102:3665–3667. - PubMed

Publication types

MeSH terms